Subscribe to RSS Please copy the URL and add it into your RSS Feed Reader. https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000131.xml Share / Bookmark Facebook X Linkedin Weibo Download PDF Synfacts 2024; 20(07): 0759DOI: 10.1055/s-0043-1774882 Innovative Drug Discovery and Development TNG908, a Clinical Candidate for PRMT5 Inhibition Exploiting Synthetic Lethality with MTAP Contributor(s): Antonia F. Stepan (Roche) , Seong Heon Kim (Hyundai Pharm) › Further Information Abstract Full Text Buy Article Permissions and Reprints Key words PRMT5 - TNG908 - synthetic lethality - MTAP - brain penetrant - glioblastoma - clinical candidate Publication History Article published online:14 June 2024 © 2024. Thieme. All rights reserved Georg Thieme Verlag KGRüdigerstraße 14, 70469 Stuttgart, Germany